Substance-Related and Addictive Disorders
Substance Use Disorders
- Pathological use of a substance that leads to a disorder of use.
- Symptom groups:
- Impaired control
- Social impairment
- Risky use
- Physical effects (i.e., intoxication, tolerance, and withdrawal)
Substances That Lead to Use Disorders
- Alcohol
- Caffeine
- Cannabis
- Hallucinogen
- Inhalant
- Opioid
- Sedative-hypnotic
- Stimulant
- Tobacco
- Other: Process addictions—Gambling, shopping, sex, etc.
Concepts Central to Addictive Use Disorders
- Addiction
- Chronic medical condition
- Intoxication
- In the process of using a substance to excess
- Tolerance
- Takes a higher dose to achieve the initial level of response
- Withdrawal
- Symptoms that occur when a person stops using a substance
Epidemiology
- Alcohol
- 15 million people addicted
- Other substances
- About 8 million people addicted
- Marijuana: 4.5 million
- Opioids: 2.0 million
Comorbidity
- Psychiatric comorbidity
- Any combination of two or more substance use disorders and mental disorders
Risk Factors
- Genetic factors
- Neurobiological factors
- Environmental factors
Clinical Picture
- Caffeine
- Most widely used psychoactive substance in the world
- Can result in intoxication, overdose, and withdrawal
- Cannabis (Marijuana)
- Third most commonly used psychoactive drug in the United States after alcohol, and illicit drugs
- Hallucinogens
- Cause a profound disturbance in reality
Clinical Picture (Cont.)
- Inhalants
- Solvents for glues and adhesives
- Propellants
- Thinners
- Fuels
Opioid Use Disorder
- Heroin and prescription drugs
- Opioid intoxication
- Cravings result in larger amounts, longer periods of use, increasing tolerance to its effects
- Results in significant impairment in life roles, interpersonal conflict, and puts a person in physically hazardous situations
Opioid Use Disorder (Cont.)
- Opioid intoxication
- Opioid overdose
- Death usually due to respiratory arrest
- Treatment: promote breathing; naloxone
Opioid Use Disorder (Cont.)
- Opioid withdrawal
- Methadone, clonidine, buprenorphine/naloxone
- Lofexidine
- Opioid maintenance
- Pharmacological
- Psychotherapies
Sedative, Hypnotic, and Antianxiety Medication Use Disorder
- Problematic Substances
- Benzodiazepines
- Benzodiazepine-like drugs
- Carbamates
- Barbiturates
- Barbiturate-like hypnotics
- Overdose: gastric lavage
- Withdrawal: gradual reduction to prevent seizures
Stimulant Use Disorder
- Clinical Picture
- Amphetamine-type, cocaine, or other stimulant drugs
- Second only to cannabis as the most widely used illicit substances in the United States
- Withdrawal treatment
- Group and individual therapy
- Possible diazepam for agitation
- 1 to 2 weeks’ cocaine withdrawal requires no inpatient care; no drugs reduce symptoms
- Depression treatment once withdrawal is complete (e.g., bupropion)
Other Disorders
- Tobacco
- Withdrawal is distressing
- Withdrawal treatment: behavioral therapy, hypnosis, nicotine replacement therapies; bupropion or verenicline
- Gambling disorder
- Gamblers Anonymous (GA)
- Possible treatment with SSRIs, bupropion (Wellbutrin), mood stabilizers, and anticonvulsants
Alcohol Use Disorder
- Sedative with initial euphoria
- Severity based on number of DSM-V symptoms
- Mild: 2–3 symptoms
- Moderate: 4–5 symptoms
- Severe: 5 or more symptoms
- Extensive List in DSM-V box
Alcohol Use Disorder (Cont.)
- Epidemiology
- Almost twice the prevalence among adult men than adult women
- American Indians/Alaska Natives (12.1%) have the highest rates; disproportionately affected by alcohol problems
- Comorbidity
- Bipolar disorders, schizophrenia, antisocial personality disorder, major depressive disorder
Alcohol Use Disorder (Cont.)
- Risk Factors
- Genetics
- Neurobiological
- Social
- Cultural
- Types of Problematic Drinking
- Binge Drinking
- Heavy Drinking
Alcohol Use Disorder (Cont.)
- Alcohol intoxication
- Legal definition of intoxication in most states: blood concentration of 80 or 100 mg ethanol per deciliter of blood (mg/dL).
- Often expressed as 0.08 to 0.10 g/dL.
- Alcohol withdrawal
- Cognitive disturbances
- Wernicke-Korsakoff syndrome
- Fetal alcohol syndrome
Alcohol Use Disorder (Cont.)
- Systemic effects
- Peripheral neuropathy
- Alcoholic myopathy and cardiomyopathy
- Esophagitis, gastritis, and pancreatitis
- Alcoholic hepatitis
- Cirrhosis of the liver
- Leukopenia
- Thrombocytopenia
- Cancer (especially head and neck)
Application of the Nursing Process
- Screening Tools
- SBIRT: Screening, brief intervention, and referral to treatment
- AUDIT: Alcohol use disorders identification test
- CAGE: 4 questions to identify alcohol abuse
- CAGE-AID: Same questions as CAGE but adds drug use to alcohol
- T-ACE: Tolerance, Annoyance, Cut down, Eye-opener
Nursing Process
- Assessment
- Family assessment (codependence)
- Self-assessment
- Nursing diagnosis
- Outcomes identification
- Planning
- Identifying problem
- Setting a goal
- Determining the interventions that will accomplish the goal
Nursing Process Implementation
- Promoting safety and sleep: first-line interventions
- Reintroduce good nutrition and hydration
- Support for self-care (hygiene)
- Exploring harmful thoughts and spiritual distress
- Health teaching and health promotion
- Prevention against genetic vulnerability
- Public classes
Nursing Process (Cont.)
- Evaluation
- Assessing the effectiveness of the treatment plan
- Using objective data to check whether nursing actions addressed the patient’s symptoms
- Measuring the changes in the patient’s behaviors for progress toward meeting stated goals
Treatment Modalities
- Pharmacotherapy
- Disulfiram
- Naltrexone
- Benzodiazepines
- Psychotherapy
- Motivational interviewing
Treatment Modalities (Cont.)
- Transtheoretical stages of change theory
- Precontemplation
- Contemplation
- Preparation
- Action
- Maintenance
Care Continuum for Substance Use Disorders
- Detoxification (detox)
- Rehabilitation
- Halfway houses
- Other housing
- Partial hospitalization program
- Intensive outpatient programs
- Outpatient treatment
- Alcoholics Anonymous (AA)
- Relapse prevention